Literature DB >> 28251447

Switch of Steady-State to an Accelerated Granulopoiesis in Response to Androctonus australis hector Venom.

Asma Kaddache1, Moustapha Hassan2,3, Fatima Laraba-Djebari4, Djelila Hammoudi-Triki1.   

Abstract

Although several studies have shown that scorpion venoms cause a systemic inflammatory response syndrome, little is known about the contribution of the hematopoietic organs. The aim of this study was to investigate the effect of Androctonus australis hector venom on the bone marrow and on local inflammatory mediators, in concordance with the systemic inflammatory reaction elicited in mice. The consequences of a direct interaction of venom with murine bone marrow cells were also assessed by in vitro study. Obtained results showed that the early systemic neutrophilia correlated with a rapid granulocyte mobilization. This response was followed by an accelerated granulopoiesis that was supported by TNF-α and IL-6 signals. In vitro data revealed that the venom exerted a proliferative effect on murine hematopoietic cells and stimulated their differentiation towards granulocyte lineage mainly through cytokine secretion. In conclusion, this study indicated that the bone marrow rapidly exerts its activity in response to the experimental envenomation via the granulopoiesis process and inflammatory mediators in concert with the development of a systemic response. The ability of venom to directly switch steady-state granulopoiesis to an accelerated state in vitro could aggravate the disturbance caused by the venom. Better understanding of the mechanisms involved may lead to the emergence of new targets to avoid cell spreading and accumulation by acting on the very early stage of the systemic inflammatory response.

Entities:  

Keywords:  bone marrow cells; granulopoiesis; neutrophilia; systemic inflammation; venom

Mesh:

Substances:

Year:  2017        PMID: 28251447     DOI: 10.1007/s10753-017-0532-6

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  46 in total

1.  Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4-expressing nonhematopoietic cells.

Authors:  Steffen Boettcher; Patrick Ziegler; Michael A Schmid; Hitoshi Takizawa; Nico van Rooijen; Manfred Kopf; Mathias Heikenwalder; Markus G Manz
Journal:  J Immunol       Date:  2012-05-14       Impact factor: 5.422

2.  Kinetics of peroxidases in guinea pig bone marrow under immunostimulation.

Authors:  E Keyhani; M A Zarei; T Lashgarblooki-Livani
Journal:  FEBS Lett       Date:  1999-06-11       Impact factor: 4.124

3.  Identification and hematopoietic potential of CD45- clonal cells with very immature phenotype (CD45-CD34-CD38-Lin-) in patients with myelodysplastic syndromes.

Authors:  Kiyoyuki Ogata; Chikako Satoh; Mikiko Tachibana; Hideya Hyodo; Hideto Tamura; Kazuo Dan; Takafumi Kimura; Yoshiaki Sonoda; Takashi Tsuji
Journal:  Stem Cells       Date:  2005-05       Impact factor: 6.277

4.  Histopathological changes and inflammatory response induced by Tityus discrepans scorpion venom in rams.

Authors:  G D'Suze; V Salazar; P Díaz; C Sevcik; H Azpurua; N Bracho
Journal:  Toxicon       Date:  2004-12-15       Impact factor: 3.033

5.  Androctonus australis hector venom contributes to the interaction between neuropeptides and mast cells in pulmonary hyperresponsiveness.

Authors:  Imène Chaïr-Yousfi; Fatima Laraba-Djebari; Djelila Hammoudi-Triki
Journal:  Int Immunopharmacol       Date:  2015-01-16       Impact factor: 4.932

6.  Combination of two antibody fragments F(ab')(2)/Fab: an alternative for scorpion envenoming treatment.

Authors:  Sassia Sami-Merah; Djelila Hammoudi-Triki; Marie-France Martin-Eauclaire; Fatima Laraba-Djebari
Journal:  Int Immunopharmacol       Date:  2008-06-17       Impact factor: 4.932

7.  Pathophysiological effects of Androctonus australis hector scorpion venom: tissue damages and inflammatory response.

Authors:  Sonia Adi-Bessalem; Djelila Hammoudi-Triki; Fatima Laraba-Djebari
Journal:  Exp Toxicol Pathol       Date:  2008-06-02

8.  Effects of Scorpion venom peptide B5 on hematopoietic recovery in irradiated mice and the primary mechanisms.

Authors:  Caixia Wang; Meixun Zhou; Ting Li; Yan Wang; Baiqian Xing; Tianhan Kong; Weihua Dong
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

9.  Scorpion venom peptide SPVII promotes irradiated cells proliferation and increases the expression of the IL-3 receptor.

Authors:  Yifang Qiu; Liyuan Jiang; Caixia Wang; Yan Wang; Ting Li; Baiqian Xing; Meixun Zhou; Tianhan Kong; Weihua Dong
Journal:  Cell Biosci       Date:  2013-07-08       Impact factor: 7.133

10.  Effects of atropine and propranolol on lung inflammation in experimental envenomation: comparison of two buthidae venoms.

Authors:  Hadjer Saidi; Sonia Adi-Bessalem; Djelila Hammoudi-Triki; Fatima Laraba-Djebari
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-04-09
View more
  4 in total

1.  Involvement of Alveolar Macrophages and Neutrophils in Acute Lung Injury After Scorpion Envenomation: New Pharmacological Targets.

Authors:  Hadjer Saidi; Julie Bérubé; Fatima Laraba-Djebari; Djelila Hammoudi-Triki
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

2.  Involvement of Toll-like Receptor 4 in Neutrophil-Mediated Inflammation, Oxidative Stress and Tissue Damage Induced by Scorpion Venom.

Authors:  Dalila Khemili; Fatima Laraba-Djebari; Djelila Hammoudi-Triki
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

3.  Mast Cells Modulate the Immune Response and Redox Status of the Gastrointestinal Tract in Induced Venom Pathogenesis.

Authors:  Nehla Zerarka-Chabane; Fatima Laraba-Djebari; Djelila Hammoudi-Triki
Journal:  Inflammation       Date:  2021-10-05       Impact factor: 4.092

Review 4.  Serotherapy against Voltage-Gated Sodium Channel-Targeting αToxins from Androctonus Scorpion Venom.

Authors:  Marie-France Martin-Eauclaire; Sonia Adi-Bessalem; Djelila Hammoudi-Triki; Fatima Laraba-Djebari; Pierre E Bougis
Journal:  Toxins (Basel)       Date:  2019-01-23       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.